U.S. Stem Cell, Inc.

Aastrom Bioscience's stem cell treatment ixmyelocel-T has improved heart function in a Phase IIa study in patients with heart failure due to dilated cardiomyopathy. The Phase IIa study presented this

IN VITRO DIAGNOSTICS University of Oslo Inven2 AS Oslo University Hospital Oxford Gene Technology Ltd. Oxford Gene Technology licenses 12 cancer biomarkers from Inven2 Inven2 AS , the tech tr

Long known for its strong manufacturing base, Ireland is in the midst of a shift emphasizing R&D and innovation, hoping to create Europe's most robust medical device cluster. The first of a two-part s

Cipla has made an indirect foray into the stem cell therapy segment through an alliance with Stempeutics Research, a leading Indian stem cell company. Under the initial phase of the alliance, Cipla is